Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Buy
60
EQH Quote, Financials, Valuation and Earnings
Last price:
$52.52
Seasonality move
:
11.57%
Day range:
$51.26 - $52.60
52-week range:
$35.49 - $56.00
Dividend yield:
1.83%
P/E ratio:
13.76x
P/S ratio:
1.37x
P/B ratio:
207.38x
Volume:
12.7M
Avg. volume:
3.2M
1-year change:
42.72%
Market cap:
$16.2B
Revenue:
$12.4B
EPS (TTM):
$3.82
Analysts' Opinion
-
Consensus RatingEquitable Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $62.70, Equitable Holdings has an estimated upside of 19.32% from its current price of $52.55.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $49.00 representing 100% downside risk from its current price of $52.55.
Fair Value
-
According to the consensus of 8 analysts, Equitable Holdings has 19.32% upside to fair value with a price target of $62.70 per share.
EQH vs. S&P 500
-
Over the past 5 trading days, Equitable Holdings has overperformed the S&P 500 by 1.98% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Equitable Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Equitable Holdings has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Equitable Holdings reported revenues of $3.6B.
Earnings Growth
-
Equitable Holdings earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Equitable Holdings reported earnings per share of $2.76.
Enterprise value:
-58B
EV / Invested capital:
--
Price / LTM sales:
1.37x
EV / EBIT:
-24.81x
EV / Revenue:
-4.66x
PEG ratio (5yr expected):
1.06x
EV / Free cash flow:
-31.30x
Price / Operating cash flow:
9.18x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.45%
Net Income Margin (TTM):
10.51%
Return On Equity:
27.07%
Return On Invested Capital:
12.5%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $12.6B | $10.5B | $12.4B | $2.2B | $3.6B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $5.43 | $3.38 | $3.82 | -$2.15 | $2.76 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $94.6B | $100.7B | $80.3B | $92B | $102.5B | |
| Total Assets | $275.4B | $292.3B | $252.7B | $276.8B | $295.9B | |
| Current Liabilities | $6.2B | $6.4B | $6.3B | $5.1B | $4.1B | |
| Total Liabilities | $258.1B | $278.7B | $249.1B | $271.7B | $292.3B | |
| Total Equity | $17.3B | $13.6B | $3.6B | $5.2B | $3.6B | |
| Total Debt | $4.4B | $5.1B | $5.2B | $5.6B | $5.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$250M | -$208M | $2B | -$392M | $400M | |
| Cash From Investing | -$7.5B | -$4.9B | -$15.9B | $115M | -$5.5B | |
| Cash From Financing | $7B | $9B | $12.4B | $2.4B | $2.5B | |
| Free Cash Flow | -$417M | -$325M | $1.9B | -$427M | $374M | |
EQH
Sector
Market Cap
$16.2B
$616.2M
Price % of 52-Week High
93.84%
85.86%
Dividend Yield
1.83%
1.99%
Shareholder Yield
8.13%
3.77%
1-Year Price Total Return
42.72%
8.45%
Beta (5-Year)
1.394
0.714
Dividend yield:
1.83%
Annualized payout:
$0.94
Payout ratio:
29.23%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$51.73
200-day SMA
Buy
Level
$45.55
Bollinger Bands (100)
Buy
Level
46.61 - 52.89
Chaikin Money Flow
Buy
Level
10.6M
20-day SMA
Buy
Level
$52.22
Relative Strength Index (RSI14)
Buy
Level
51.84
ADX Line
Sell
Level
7.14
Williams %R
Sell
Level
-17.5221
50-day SMA
Buy
Level
$52.47
MACD (12, 26)
Buy
Level
7.42
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
9.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.5506)
Sell
CA Score
(Annual)
Level (-2.6738)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.7882)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.
Stock Forecast FAQ
In the current month, EQH has received 5 Buy ratings 3 Hold ratings, and 0 Sell ratings. The EQH average analyst price target in the past 3 months is $62.70.
-
Where Will Equitable Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Equitable Holdings share price will rise to $62.70 per share over the next 12 months.
-
What Do Analysts Say About Equitable Holdings?
Analysts are divided on their view about Equitable Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Equitable Holdings is a Sell and believe this share price will drop from its current level to $49.00.
-
What Is Equitable Holdings's Price Target?
The price target for Equitable Holdings over the next 1-year time period is forecast to be $62.70 according to 8 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is EQH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Equitable Holdings is a Buy. 5 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EQH?
You can purchase shares of Equitable Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Equitable Holdings shares.
-
What Is The Equitable Holdings Share Price Today?
Equitable Holdings was last trading at $52.52 per share. This represents the most recent stock quote for Equitable Holdings. Yesterday, Equitable Holdings closed at $52.55 per share.
-
How To Buy Equitable Holdings Stock Online?
In order to purchase Equitable Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
